Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

VRCAVRCA
31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in Verrica Pharmaceuticals Inc.

BNP PARIBAS FINANCIAL MARKETS holds 110 shares of VRCA (Verrica Pharmaceuticals Inc.), worth $673 as of 2026-Q2.

Current Value

$673

Current Shares

110

Total Value Change

+$649

Total Shares Change

+107

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
110
0.0%
$6730.0%$6.12
0
2026-Q1
Unchanged
110
0.0%
$5820.0%$5.12
0
2025-Q4
Decreased
110
-11.3%
$9140.0%$8.30
0
2025-Q3
Decreased
124
-91.0%
$5340.0%$4.30
0
2025-Q2
Decreased
1,379
-50.0%
$7310.0%$5.23
0
2025-Q1
Increased
2,761
+3.2%
$1,2210.0%$4.33
8
2024-Q4
Decreased
2,675
-37.1%
$1,8720.0%$7.00
0
2024-Q3
Increased
4,253
+162.4%
$6,1670.0%$16.90
17
2024-Q2
Decreased
1,621
-84.3%
$11,8170.0%$72.90
0
2024-Q1
Decreased
10,342
-74.1%
$61,2250.0%$59.20
0
2023-Q4
Increased
39,988
+210.9%
$292,7120.0%$73.20
38
2023-Q3
Increased
12,861
+110.5%
$49,9650.0%$38.85
33
2023-Q2
Increased
6,110
+879.2%
$35,2550.0%$57.60
22
2023-Q1
Decreased
624
-54.9%
$4,0560.0%$66.40
0
2022-Q4
Increased
1,384
+171.4%
$3,8060.0%$27.50
15
2022-Q3
Decreased
510
-96.0%
$1,4890.0%$27.90
0
2022-Q2
Increased
12,678
+955.6%
$24,3420.0%$21.70
21
2022-Q1
Decreased
1,201
-73.3%
$9,7400.0%$81.80
0
2021-Q4
Increased
4,489
+74.1%
$41,1190.0%$95.30
30
2021-Q3
Increased
2,579
+307.4%
$32.2M0.0%$123.10
32
2021-Q2
Decreased
633
-64.2%
$7,1530.0%$116.30
0
2021-Q1
Decreased
1,770
-37.4%
$26,8160.0%$136.80
0
2020-Q4
Decreased
2,827
-14.3%
$32,5390.0%$119.70
0
2020-Q3
Increased
3,298
+360.6%
$25,5270.0%$80.80
21
2020-Q2
Decreased
716
-82.2%
$7,8830.0%$140.70
0
2020-Q1
Increased
4,017
+54.2%
$43,9060.0%$114.20
29
2019-Q4
Increased
2,605
+40.1%
$41,3930.0%$153.20
27
2019-Q3
Increased
1,859
+17.4%
$27,4390.0%$125.20
15
2019-Q2
Decreased
1,583
-30.0%
$18,3940.0%$116.20
0
2019-Q1
Increased
2,261
+753x
$24,4410.0%$108.10
31
2018-Q4
New
3
-
$240.0%$87.80
17

Other major holders of VRCA: Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used